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INTRODUCTION
The overlapping of pharmacokinetics and/or 
the pharmacodynamics of medicines causes 
the occurrence of overlapping clinical 
syndromes and diagnostic issues, potentiated 
in overdoses. We report a case of severe 
venlafaxine poisoning where the clinical 
presentation and the results of rapid 
immunoassay test overlapped with tramadol 
intoxication.
MATIRIALS AND METHODS
Case presentation. An unconscious women 
with recurrent seizers, hypertension and 
supposed acute medication poisoning in 
suicidal attempt was transported to our clinic. 
Previously, she had been lavaged, rehydrated 
and treated with 20 mg diazepam iv, 40 mg 
furosemide at the local general hospital. Her 
regular tablet therapy consisted of losartan, 
levothyroxine, venlafaxine, occasionally 
tramadol.
DISCUSSION
At admission she was comatose, with isochoric normal pupils, BP 
130/80 mm Hg, SaO2 86%, and recurrent episodes of seizures 
treated with 10mg diazepam iv, ocular clonus, hypertonus, 
temperature 38.9C, diaphoresis, facial hyperaemia, dark coloured
urine, hyponatremia and rhabdomyolisis. The lateral flow 
immunoassay (AbuGnostR) was positive for tramadol, but the 
homogeneous enzyme immunoassay did not confirm it. After 36 
hours of intensive treatment she became somnolent and reported 
ingestion of 2250 mg tbl Venlafaxine. The AbuGnost R test 
detects tramadol at cut off urine values 200ng/ml, but present 
cross reactivity with O-desmethylvenlafaxine at cut off values up 
to 25000ng/ml. The following days she complained of muscular 
weakness, headaches and cognitive impairment, which lasted for 
more then one month after release from hospital.
Results
High concentrations of venlafaxine 
metabolites induce false positive tramadol 
immunoassay (AbuGnostR) test. 
Conclusion
Overlapping clinical presentations and 
metabolic pathways of venlafaxine and 
tramadol should alert physicians when 
interpret rapid immunoassay test. The 
mandatory principle when making medical 
decisions should cover synthesis of critically 
interpreted toxicology analysis, interview data 
and clinical features of the poisoning, which 
may help to avoid misleading conclusions and 
improve the diagnostic and therapy decisions
